BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29396515)

  • 21. Inflammatory biomarkers for AMD.
    Stanton CM; Wright AF
    Adv Exp Med Biol; 2014; 801():251-7. PubMed ID: 24664705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An adenosine A1R-A2aR imbalance regulates low glucose/hypoxia-induced microglial activation, thereby contributing to oligodendrocyte damage through NF-κB and CREB phosphorylation.
    Huang W; Bai S; Zuo X; Tang W; Chen P; Chen X; Wang G; Wang H; Xie P
    Int J Mol Med; 2018 Jun; 41(6):3559-3569. PubMed ID: 29512780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 7-Ketocholesterol increases retinal microglial migration, activation, and angiogenicity: a potential pathogenic mechanism underlying age-related macular degeneration.
    Indaram M; Ma W; Zhao L; Fariss RN; Rodriguez IR; Wong WT
    Sci Rep; 2015 Mar; 5():9144. PubMed ID: 25775051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receptor for advanced glycation end products and age-related macular degeneration.
    Howes KA; Liu Y; Dunaief JL; Milam A; Frederick JM; Marks A; Baehr W
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3713-20. PubMed ID: 15452081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the adenosine A2A receptor antagonist SCH 58621 on cyclooxygenase-2 expression, glial activation, and brain-derived neurotrophic factor availability in a rat model of striatal neurodegeneration.
    Minghetti L; Greco A; Potenza RL; Pezzola A; Blum D; Bantubungi K; Popoli P
    J Neuropathol Exp Neurol; 2007 May; 66(5):363-71. PubMed ID: 17483693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
    J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenosine A
    Akbari A; Khalili-Fomeshi M; Ashrafpour M; Moghadamnia AA; Ghasemi-Kasman M
    Life Sci; 2018 Jul; 205():63-72. PubMed ID: 29730168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysregulated autophagy in the RPE is associated with increased susceptibility to oxidative stress and AMD.
    Mitter SK; Song C; Qi X; Mao H; Rao H; Akin D; Lewin A; Grant M; Dunn W; Ding J; Bowes Rickman C; Boulton M
    Autophagy; 2014; 10(11):1989-2005. PubMed ID: 25484094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic Opportunities for Caffeine and A2A Receptor Antagonists in Retinal Diseases.
    Boia R; Ambrósio AF; Santiago AR
    Ophthalmic Res; 2016; 55(4):212-8. PubMed ID: 26959995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual blockade of the A1 and A2A adenosine receptor prevents amyloid beta toxicity in neuroblastoma cells exposed to aluminum chloride.
    Giunta S; Andriolo V; Castorina A
    Int J Biochem Cell Biol; 2014 Sep; 54():122-36. PubMed ID: 25058312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and synthesis of (4E)-4-(4-substitutedbenzylideneamino)-3-substituted-2,3-dihydro-2-thioxothiazole-5-carbonitrile as novel A2A receptor antagonists.
    Mishra CB; Sharma D; Prakash A; Kumari N; Kumar N; Luthra PM
    Bioorg Med Chem; 2013 Oct; 21(19):6077-83. PubMed ID: 23953686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of Microglial Activation by Adenosine A2a Receptor in Animal Models of Perinatal Brain Injury.
    Colella M; Zinni M; Pansiot J; Cassanello M; Mairesse J; Ramenghi L; Baud O
    Front Neurol; 2018; 9():605. PubMed ID: 30254599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction.
    Rebola N; Simões AP; Canas PM; Tomé AR; Andrade GM; Barry CE; Agostinho PM; Lynch MA; Cunha RA
    J Neurochem; 2011 Apr; 117(1):100-11. PubMed ID: 21235574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperhomocysteinemia disrupts retinal pigment epithelial structure and function with features of age-related macular degeneration.
    Ibrahim AS; Mander S; Hussein KA; Elsherbiny NM; Smith SB; Al-Shabrawey M; Tawfik A
    Oncotarget; 2016 Feb; 7(8):8532-45. PubMed ID: 26885895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Light induces NLRP3 inflammasome activation in retinal pigment epithelial cells via lipofuscin-mediated photooxidative damage.
    Brandstetter C; Mohr LK; Latz E; Holz FG; Krohne TU
    J Mol Med (Berl); 2015 Aug; 93(8):905-16. PubMed ID: 25783493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minocycline counter-regulates pro-inflammatory microglia responses in the retina and protects from degeneration.
    Scholz R; Sobotka M; Caramoy A; Stempfl T; Moehle C; Langmann T
    J Neuroinflammation; 2015 Nov; 12():209. PubMed ID: 26576678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement deposition and microglial activation in the outer retina in light-induced retinopathy: inhibition by a 5-HT1A agonist.
    Collier RJ; Wang Y; Smith SS; Martin E; Ornberg R; Rhoades K; Romano C
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8108-16. PubMed ID: 21467172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenosine A
    Wang YQ; Li R; Wang DR; Cherasse Y; Zhang Z; Zhang MQ; Lavielle O; McEown K; Schiffmann SN; de Kerchove d'Exaerde A; Qu WM; Lazarus M; Huang ZL
    Brain Struct Funct; 2017 Apr; 222(3):1351-1366. PubMed ID: 27485749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stem cell based therapies for age-related macular degeneration: The promises and the challenges.
    Nazari H; Zhang L; Zhu D; Chader GJ; Falabella P; Stefanini F; Rowland T; Clegg DO; Kashani AH; Hinton DR; Humayun MS
    Prog Retin Eye Res; 2015 Sep; 48():1-39. PubMed ID: 26113213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenosine A2A receptor signaling affects IL-21/IL-22 cytokines and GATA3/T-bet transcription factor expression in CD4
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Almutairi MM; Attia SM
    J Neuroimmunol; 2017 Oct; 311():59-67. PubMed ID: 28807491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.